Stock listing
6LP0 Stock Price, News, Filings & Events — Bolt Biotherapeutics, Inc.
Selected listing: 6LP0 · GETTEX · EUR · DE
This page tracks Bolt Biotherapeutics, Inc.'s 6LP0:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 6LP0:GETTEX. 6LP0:GETTEX is the stock-level entry point for investors researching Bolt Biotherapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 6LP0:GETTEX
- Asset type
- Stock
- Market cap
- $7.5M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- GETTEX
- Currency
- EUR
Bolt Biotherapeutics, Inc. 6LP0:GETTEX stock context
This page tracks Bolt Biotherapeutics, Inc.'s 6LP0:GETTEX listing on GETTEX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 6LP0:GETTEX. 6LP0:GETTEX is the stock-level entry point for investors researching Bolt Biotherapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 11, 2026
Bolt Biotherapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
May 12, 2026
Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
March 12, 2026
Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update
November 12, 2025
Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027
October 1, 2025
Bolt Biotherapeutics, Inc. earnings calls
Research Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc. investor report
Review AI stock analysis and investor report context for 6LP0:GETTEX.
Bolt Biotherapeutics, Inc. company profile
View the public company page for Bolt Biotherapeutics, Inc. on 6ix.
Bolt Biotherapeutics, Inc. news
Read company news and market updates connected to Bolt Biotherapeutics, Inc..
Bolt Biotherapeutics, Inc. investor events
Find investor webinars, events, and replay context for Bolt Biotherapeutics, Inc..
Alternate listings
BOLT:NASDAQ
US · USD
Alternate listing for Bolt Biotherapeutics, Inc.; the primary context on this page is 6LP0:GETTEX.
BOLT:BOATS
US · USD
Alternate listing for Bolt Biotherapeutics, Inc.; the primary context on this page is 6LP0:GETTEX.
6LP0:FWB
DE · EUR
Alternate listing for Bolt Biotherapeutics, Inc.; the primary context on this page is 6LP0:GETTEX.
A419U9:LS
DE · EUR
Alternate listing for Bolt Biotherapeutics, Inc.; the primary context on this page is 6LP0:GETTEX.
A419U9:LSX
DE · EUR
Alternate listing for Bolt Biotherapeutics, Inc.; the primary context on this page is 6LP0:GETTEX.
6LP0:MUN
DE · EUR
Alternate listing for Bolt Biotherapeutics, Inc.; the primary context on this page is 6LP0:GETTEX.